GCM
ACAD icon

Glaxis Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Glaxis Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-13,200
Closed -$362K – 34
2013
Q3 		$362K Buy
+13,200
New +$362K 0.73% 37